Newmark Group Inc. has successfully arranged the sale of the Burlington BioCenter, a premier life science facility located in Burlington, Massachusetts. The transaction was led by Newmark Co-Head of U.S. Capital Markets Robert Griffin, alongside other key executives. The buyer, an owner-user, has chosen to remain unnamed. The Burlington BioCenter, completed in 2019 with interior laboratory buildouts finished in 2022, features state-of-the-art laboratory infrastructure and premium finishes. Situated at 4 Burlington Woods Drive, the property offers excellent accessibility and is part of a thriving suburban life science cluster. Comprising 109,085 square feet across four stories, it stands out in the Burlington submarket for its turnkey laboratory infrastructure and immediate occupancy potential.